Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37653361/
The guidelines released by the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) in 2022 and those released in 2021 by the European Society of Cardiology (ESC)...
The 2022 ACC/AHA/HFSA and 2021 ESC guidelines for heart failure align on key recommendations but differ due to timing; this review highlights differences to support evidence-based clinical decision-making.
Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2 - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38970586/
Comorbidities naturally clustered into 5 mutually exclusive groups in RELAX-AHF-2, showing variations in clinical outcomes. These data emphasize that the specific combination of comorbidities can influence adverse outcomes and treatment...
The study identified five multimorbidity groups in acute heart failure patients, highlighting distinct clinical outcomes and treatment responses, emphasizing the importance of comorbidity patterns in managing these patients.
Cardiorenal interactions in heart failure: insights from recent therapeutic advances - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37364186/
Heart failure is a syndrome that may develop when cardiovascular disease progresses or is insufficiently treated and associated with a poor quality of life, high mortality rates, and increased healthcare...
New therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs, enhance cardiovascular and renal outcomes in high-risk patients with diabetes and heart failure, significantly improving patient management.
Feasibility of a digital palliative care intervention (Convoy-Pal) for older adults with heart failure and multiple chronic conditions and their caregivers: a waitlist randomized control trial
Source : https://pubmed.ncbi.nlm.nih.gov/39354453/
ClinicalTrials.gov Identifier NCT04779931. Date of registration: March 3, 2021.
The Convoy-Pal intervention demonstrated feasibility and potential benefits for heart failure patients and their caregivers, highlighting the need for digital tools that effectively integrate both parties in palliative care.
Efficacy of catheter ablation for atrial fibrillation in heart failure: a meta-analysis of randomized controlled trials
Source : https://pubmed.ncbi.nlm.nih.gov/38661235/
The study aims to evaluate whether rhythm control by catheter ablation is superior to medical therapy for the patients with atrial fibrillation (AF) and heart failure (HF). The literatures were...
Catheter ablation significantly improves survival, reduces heart failure re-hospitalization, enhances left ventricular function, and quality of life in atrial fibrillation patients with heart failure compared to medical therapy.